On the 100th anniversary of Lipiodol’s introduction as a contrast agent in radiology, research is turning to the role of Lipiodol TACE (cTACE) in combination treatments for Hepatocellular...
Interview with Dr Choo Su Pin to shed light on a new generation of therapies that could improve the prognosis of liver cancer patients. Liver cancer is the sixth most common cancer worldwide, which...
Presenting their results at the ESMO Asia Congress in 2019, researchers of the IMbrave150 study show for the first time in a decade a new class of treatment for hepatocellular carcinoma. The study...
